Hematology

New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.

A study has highlighted the clinical significance of circulating tumour cells in the blood of multiple myeloma patients, proposing a new cutoff that could enhance treatment outcomes.

A new program has shown promising results in reducing distress and fatigue among blood cancer patients who have undergone haematopoietic stem cell transplants.

A recent study has found that immunoglobulin replacement therapy significantly decreases the incidence of infections and antimicrobial use in patients with chronic lymphocytic leukemia.

A recent study reveals that older adults with acute myeloid leukaemia receiving hypomethylating agents enjoy significantly more home time compared to those on anthracycline-based therapy

A recent study has shed light on the complex interactions contributing to lung injury in paediatric patients undergoing hematopoietic cell transplantation.

Recent research has revealed that the red blood cell distribution width to albumin concentration ratio is associated with increased all-cause and cause-specific mortality.

Frontline treatment with acalabrutinib, bendamustine, and rituximab shows promising results in reducing disease progression and death in older mantle cell lymphoma patients.